• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症的预后因素:中德之间的比较。

Prognostic factors in ALS: a comparison between Germany and China.

机构信息

Department of Neurology, Universitätsklinik Ulm, RKU, Oberer Eselsberg 45, 89081, Ulm, Germany.

Department of Neurology, Peking University Third Hospital, Beijing, 100191, China.

出版信息

J Neurol. 2019 Jun;266(6):1516-1525. doi: 10.1007/s00415-019-09290-4. Epub 2019 Mar 28.

DOI:10.1007/s00415-019-09290-4
PMID:30923935
Abstract

OBJECTIVE

Several independent prognostic factors, such as age of onset, type of onset, body mass index (BMI), and progression rate have been identified for amyotrophic lateral sclerosis (ALS) in Caucasians. The aim of this study was to identify such factors in Chinese patients and to compare their impact with German patients.

METHODS

Comparison of prognostic factors was based on two hospital-based registries. The registry of the German Network for Motor Neuron Diseases contains 3100 patients with ALS. The Chinese registry comprises 2101 patients who were collected between 2003 and 2015 in the metropolitan area of Beijing.

RESULTS

Disease progression was slower in China [median loss of 0.50 points (IQR 0.26-0.87 points) versus 0.55 points (IQR 0.28-1.00 points) of ALS functional rating scale revised (ALS-FRS-R) score per month; p < 0.0001]. Survival of patients with ALS was similar in Germany and China (p > 0.05). We found that younger age of onset (p < 0.0001), spinal onset (p < 0.0001), high BMI (p < 0.0001) and low progression rate (p < 0.0001) were positive prognostic factors in China as well as in Germany.

INTERPRETATION

Prognostic factors, which are known to modify the course of disease in Caucasians, apply to Chinese patients as well. The results indicate that despite the apparent differences regarding genotype and clinical phenotype, findings from interventional studies in Caucasians aiming at disease-modifying prognostic factors (such as body weight) may be transferred to Chinese patients.

摘要

目的

几项独立的预后因素,如发病年龄、发病类型、体重指数(BMI)和进展速度,已被确定为白种人肌萎缩侧索硬化症(ALS)的预后因素。本研究的目的是确定中国患者的这些因素,并与德国患者进行比较。

方法

基于两个基于医院的登记处比较预后因素。德国运动神经元疾病网络的登记处包含 3100 名 ALS 患者。中国的登记处包括 2101 名患者,这些患者是在 2003 年至 2015 年间在北京大都市区收集的。

结果

中国的疾病进展速度较慢[中位数丢失 0.50 分(IQR 0.26-0.87 分)与 ALS 功能评定量表修订版(ALS-FRS-R)评分每月 0.55 分(IQR 0.28-1.00 分);p<0.0001]。德国和中国的 ALS 患者的生存率相似(p>0.05)。我们发现,中国和德国的发病年龄较小(p<0.0001)、脊髓发病(p<0.0001)、BMI 较高(p<0.0001)和进展速度较慢(p<0.0001)是阳性预后因素。

结论

已知会改变白种人疾病进程的预后因素也适用于中国患者。这些结果表明,尽管在基因型和临床表型方面存在明显差异,但针对疾病修饰预后因素(如体重)的干预性研究在白种人中的发现可能会被转移到中国患者身上。

相似文献

1
Prognostic factors in ALS: a comparison between Germany and China.肌萎缩侧索硬化症的预后因素:中德之间的比较。
J Neurol. 2019 Jun;266(6):1516-1525. doi: 10.1007/s00415-019-09290-4. Epub 2019 Mar 28.
2
Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.中国和德国肌萎缩侧索硬化症(ALS)的表型差异。
J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1.
3
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.生命历程体重指数与肌萎缩侧索硬化症的风险和预后:来自 ALS 登记处 Swabia 的结果。
Eur J Epidemiol. 2017 Oct;32(10):901-908. doi: 10.1007/s10654-017-0318-z. Epub 2017 Oct 3.
4
Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort.中国大样本队列研究肌萎缩侧索硬化的流行病学及生存预测因素。
Chin Med J (Engl). 2021 Sep 2;134(18):2231-2236. doi: 10.1097/CM9.0000000000001679.
5
Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.影响肌萎缩侧索硬化症患者纵向功能衰退和生存的因素。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):230-6. doi: 10.3109/21678421.2014.990036. Epub 2014 Dec 30.
6
The predictors of survival in Chinese amyotrophic lateral sclerosis patients.中国肌萎缩侧索硬化症患者生存的预测因素。
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):237-44. doi: 10.3109/21678421.2014.993650. Epub 2015 Jan 12.
7
Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.肌萎缩侧索硬化功能评定量表修订版(ALSFRS-R)评分下降及生存情况的异质性:意大利一项基于人群的研究
Neurol Sci. 2015 Dec;36(12):2243-52. doi: 10.1007/s10072-015-2343-6. Epub 2015 Jul 24.
8
Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population-based registry in southwest Germany.他汀类药物、糖尿病和肌萎缩侧索硬化症的预后:来自德国西南部一个基于人群的登记处的 501 名患者的数据。
Eur J Neurol. 2020 Aug;27(8):1405-1414. doi: 10.1111/ene.14300. Epub 2020 Jun 2.
9
Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.中国散发性肌萎缩侧索硬化的自然史和临床特征。
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1075-81. doi: 10.1136/jnnp-2015-310471. Epub 2015 Jun 29.
10
Factors predicting one-year mortality in amyotrophic lateral sclerosis patients--data from a population-based registry.肌萎缩侧索硬化症患者一年死亡率的预测因素——来自基于人群的登记处的数据。
BMC Neurol. 2014 Oct 4;14:197. doi: 10.1186/s12883-014-0197-9.

引用本文的文献

1
Prognostic factors in ALS: different approaches to the same problem.肌萎缩侧索硬化症的预后因素:针对同一问题的不同方法。
Arq Neuropsiquiatr. 2025 Jun;83(6):1-7. doi: 10.1055/s-0045-1809407. Epub 2025 Jun 20.
2
Clinical assessment and interpretation of dysarthria in ALS using attention based deep learning AI models.使用基于注意力的深度学习人工智能模型对肌萎缩侧索硬化症中的构音障碍进行临床评估和解读。
NPJ Digit Med. 2025 May 8;8(1):260. doi: 10.1038/s41746-025-01654-7.
3
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?

本文引用的文献

1
Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.中国和德国肌萎缩侧索硬化症(ALS)的表型差异。
J Neurol. 2018 Apr;265(4):774-782. doi: 10.1007/s00415-018-8735-9. Epub 2018 Feb 1.
2
Using the Capture-Recapture Method to Estimate the Incidence of Amyotrophic Lateral Sclerosis in Beijing, China.应用捕获-再捕获法估计中国北京地区肌萎缩侧索硬化症的发病率。
Neuroepidemiology. 2018;50(1-2):29-34. doi: 10.1159/000486175. Epub 2018 Jan 11.
3
Epidemiology of amyotrophic lateral sclerosis in Southern Germany.
肌萎缩侧索硬化症中基于人群的数据与基于医院的数据——一个需要考虑的因素?
Eur J Neurol. 2025 Apr;32(4):e70137. doi: 10.1111/ene.70137.
4
Tofersen and other antisense oligonucleotides in ALS.托非生及肌萎缩侧索硬化症中的其他反义寡核苷酸。
Ther Adv Neurol Disord. 2025 Jan 22;18:17562864251313915. doi: 10.1177/17562864251313915. eCollection 2025.
5
Incidence and mortality of ALS: a 42-year population-based nationwide study.肌萎缩侧索硬化症的发病率和死亡率:一项基于全国人口的42年研究。
J Neurol. 2024 Dec 12;272(1):44. doi: 10.1007/s00415-024-12743-0.
6
Phrenic Nerve Sonography Alterations in Patients with ALS: Insight with Clinical and Neurophysiological Findings.肌萎缩侧索硬化症患者膈神经超声检查的改变:结合临床和神经生理学发现的见解
J Clin Med. 2024 Oct 22;13(21):6302. doi: 10.3390/jcm13216302.
7
Update on recent advances in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的最新进展综述。
J Neurol. 2024 Jul;271(7):4693-4723. doi: 10.1007/s00415-024-12435-9. Epub 2024 May 27.
8
Analysis of repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS).对格鲁吉亚肌萎缩侧索硬化症(ALS)患者重复序列扩增的分析。
F1000Res. 2024 Mar 6;12:1113. doi: 10.12688/f1000research.138436.1. eCollection 2023.
9
Sonographic Phrenic Nerve Changes in Amyotrophic Lateral Sclerosis.超声膈神经变化在肌萎缩侧索硬化症中的表现。
Medicina (Kaunas). 2023 Sep 29;59(10):1745. doi: 10.3390/medicina59101745.
10
Nutritional and metabolic factors in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的营养和代谢因素。
Nat Rev Neurol. 2023 Sep;19(9):511-524. doi: 10.1038/s41582-023-00845-8. Epub 2023 Jul 27.
德国南部地区肌萎缩侧索硬化症的流行病学。
J Neurol. 2017 Apr;264(4):749-757. doi: 10.1007/s00415-017-8413-3. Epub 2017 Feb 20.
4
Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.肌萎缩侧索硬化症的遗传流行病学:系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):540-549. doi: 10.1136/jnnp-2016-315018. Epub 2017 Jan 5.
5
The concept and diagnostic criteria of primary lateral sclerosis.原发性侧索硬化症的概念及诊断标准。
Acta Neurol Scand. 2017 Sep;136(3):204-211. doi: 10.1111/ane.12713. Epub 2016 Nov 15.
6
Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.中国散发性肌萎缩侧索硬化的自然史和临床特征。
J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1075-81. doi: 10.1136/jnnp-2015-310471. Epub 2015 Jun 29.
7
Association between diabetes and amyotrophic lateral sclerosis in Sweden.瑞典糖尿病与肌萎缩侧索硬化症之间的关联。
Eur J Neurol. 2015 Nov;22(11):1436-42. doi: 10.1111/ene.12632. Epub 2015 Jan 19.
8
Epidemiological characteristics of motor neuron disease in Chinese patients.中国运动神经元病患者的流行病学特征。
Acta Neurol Scand. 2014 Aug;130(2):111-7. doi: 10.1111/ane.12240. Epub 2014 Apr 1.
9
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.肌萎缩侧索硬化症患者的高卡路里肠内营养:一项随机、双盲、安慰剂对照的 2 期试验。
Lancet. 2014 Jun 14;383(9934):2065-2072. doi: 10.1016/S0140-6736(14)60222-1. Epub 2014 Feb 28.
10
The epidemiology of ALS: a conspiracy of genes, environment and time.肌萎缩侧索硬化症的流行病学:基因、环境与时间的共谋。
Nat Rev Neurol. 2013 Nov;9(11):617-28. doi: 10.1038/nrneurol.2013.203. Epub 2013 Oct 15.